Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
…, PR Bauer, JE Blair, CM van Buskirk… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
…, PR Bauer, JE Blair, CM Van Buskirk… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19
…, NC Verdun, P Marks, CM van Buskirk… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …
under the presumption that such plasma contains potentially therapeutic …
[HTML][HTML] Red blood cell storage lesion
The past two decades have witnessed increased scrutiny regarding efficacy and risk of the
once unquestioned therapy of red blood cell (RBC) transfusion. Simultaneously, a variety of …
once unquestioned therapy of red blood cell (RBC) transfusion. Simultaneously, a variety of …
[HTML][HTML] Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
…, R Goel, CC Wiggins, KA Bruno, CM van Buskirk… - PLoS …, 2021 - journals.plos.org
Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
[HTML][HTML] Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
…, DL Fairweather, RS Wright, CM van Buskirk… - Nature …, 2021 - nature.com
Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial
…, CM Van Buskirk, JL Winters, M Malinchoc… - American journal of …, 2012 - atsjournals.org
Rationale: Transfusion-related pulmonary complications are leading causes of morbidity and
mortality attributed to transfusion. Observational studies suggest an important role for red …
mortality attributed to transfusion. Observational studies suggest an important role for red …
Reductions in central venous pressure by lower body negative pressure or blood loss elicit similar hemodynamic responses
…, TB Curry, CM Van Buskirk… - Journal of applied …, 2014 - journals.physiology.org
The purpose of this study was to compare hemodynamic and blood analyte responses to
reduced central venous pressure (CVP) and pulse pressure (PP) elicited during graded lower …
reduced central venous pressure (CVP) and pulse pressure (PP) elicited during graded lower …
[HTML][HTML] Temporal sequence of major biochemical events during blood bank storage of packed red blood cells
BS Karon, CM Van Buskirk, EA Jaben, JD Hoyer… - Blood …, 2012 - ncbi.nlm.nih.gov
Background. We used sensitive spectroscopic techniques to measure changes in Band 3
oligomeric state during storage of packed red blood cells (RBC); these changes were …
oligomeric state during storage of packed red blood cells (RBC); these changes were …
[HTML][HTML] Rates among hospitalized patients with COVID-19 treated with Convalescent plasma: A systematic review and meta-analysis
…, ES Theel, CM van Buskirk, N van Helmond… - … : Innovations, Quality & …, 2023 - Elsevier
Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19. …
mortality and the differences between subgroups in hospitalized patients with COVID-19. …